Pfizer just announced that the U.S. Food and Drug Administration (FDA) issued an approvable letter for maraviroc, as a therapy for HIV patients. Labeling is not yet finalized.
Pfizer did not comment on the ongoing investigation related to unapproved marketing allegations by a sales rep.
You can read that story here.
Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Follow on https://twitter.com/peterrost
Wednesday, June 20, 2007
Pfizer Receives Approvable Letter For Maraviroc. Investigation Continues.
Subscribe to:
Post Comments (Atom)
1 comment:
Now they can make it legal...once they submit their marketing plan ha ha ha ha we have the slides so we already know what it is more of the same off label, unbranded promotion of an almost approved drug. Oh well they always win $$$$$
Post a Comment